Indication
Dopamine beta-hydroxylase deficiency
1 clinical trial
1 product
Clinical trial
A Multi-center, Open-label Study to Assess the Long-term Safety of Droxidopa in Subjects With Primary Autonomic Failure, Dopamine Beta Hydroxylase Deficiency or Non-Diabetic Neuropathy and Symptomatic Neurogenic Orthostatic HypotensionStatus: Completed, Estimated PCD: 2013-02-01
Product
Droxidopa